Antimicrobial Resistance Diagnostic Markets Transforming Global Healthcare with Innovative Technologies and Trends 2023-2027 - ResearchAndMarkets.com
19 Feb 2024
Diagnostic Reagents
DUBLIN--(BUSINESS WIRE)--The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
'Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides 2023 to 2027'
The healthcare sector is on the cusp of a revolution with the latest advancements in diagnostic technologies geared towards combatting antimicrobial resistance (AMR). This new comprehensive research publication analyzes the burgeoning market and the potential these technologies hold in the fight against one of the most pressing healthcare challenges of our time.
This report presents an in-depth analysis of the AMR diagnostic market, providing a clear understanding of the various diagnostic methods emerging to identify pathogens and infections. It dissects the new diagnostic technologies beyond gene sequencing that are gaining traction in this evolving market landscape.
The research underscores the strategic market opportunities against AMR by detailing the six key large pathogen opportunities poised for significant growth. This is an indispensable insight for industry investors and healthcare stakeholders seeking to stay ahead of the curve in a rapidly changing market.
Furthermore, the report offers a comprehensive profiling of over 30 companies actively involved in developing groundbreaking diagnostic solutions. These profiles include established industry giants as well as nascent players who are introducing innovation and driving growth in the AMR diagnostic space.
Apart from the technological evaluation and strategic market insights, the document delves into the trends influencing the global AMR diagnostics market from 2023 to 2027. It is instrumental for formulating data-driven decisions and aligning business strategies with the market dynamics.
The insights provided in the report are crucial for industry professionals, healthcare providers, and policy-makers who are navigating the challenges of antimicrobial resistance. It serves as a roadmap to understanding the evolving technologies and market strategies that will play a crucial role in the global healthcare system.
Plain language analysis of the diverse diagnostic techniques
Forecasted market data for major pathogen diagnostic opportunities
Extensive company profiles spanning major industry participants
Valuable perspectives on emerging trends and market growth areas
As the healthcare industry grapples with the enormity of antimicrobial resistance, this report is an essential resource providing clarity and direction for those at the forefront of medical diagnostics innovation.
Key Topics Covered:
Antibiotic Resistance Diagnostics Recent Developments
Antibiotic Resistance Recent Developments
FDA Clears New bioMerieux Diagnostic System and Panel
Selux Diagnostics Phenotyping System Gets FDA Approval
New diagnostics to tackle drug resistant infections
Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Infectious Disease Panels
Three companies join forces to tackle antimicrobial resistance (AMR)
T2 Biosystems Exercises BARDA Option
OpGen to Ramp up Use of Acuitas AMR Gene Panel
OpGen Receives FDA Clearance for AMR Panel
Visby Medical - Rapid Uptake of Handheld PCR Test for STIs
MicroGenDx, OrthoKey Clinic and OrthoKey Surgery
BioMerieux Receives CE Mark for Vitek Clinical Microbiology System
Hologic to Acquire Mobidiag
Campylobacter strains exchange genes
Disinfection spreads antimicrobial resistance
Accelerate Diagnostics Expands AMR Testing
Rapid diagnostics linked to optimal antibiotics
Visby Medical Wins AMR Diagnostic Competition
DNAe Technology SARS-CoV-2 Sequences
Infections with foodborne bacteria becoming harder to treat
Dust is sharing antibiotic resistance genes
1928 Diagnostics
ADT Biotech
Becton, Dickinson and Company
Cepheid (Danaher)
Curetis N.V. / Curetis GmbH
Genetic Signatures
Hologic
Millipore Sigma
Perkin Elmer
Sense Biodetection
Siemens Healthineers
The Global Market for Antimicrobial Resistance Diagnostics
Global Antibiotic Resistance Diagnostic Markets - By Pathogen
Global Antibiotic Resistance Diagnostic Markets - by Technology
Vision of the Future of AMR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/dm4ikm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.